The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1
Eb. Liu et al., The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1, CANCER RES, 60(9), 2000, pp. 2361-2364
To search for the intracellular signaling pathway critical for the secretio
n of matrix metalloproteinases (MMP), we studied the effects of dominant ne
gative Ras (S17N Ras) and dominant negative MEK1 (MEK1AA) expression in v-c
rk-transformed 3Y1. Expression of either S17N Ras or MEK1AA dramatically su
ppressed the augmented secretion of MMP-2 and MMP-9 in v-crk-transfected 3Y
1. Similarly, a Ras farnesyltransferase inhibitor, manumycin A, and a MEK1
inhibitor, U0126, suppressed MMP secretion in a dose-dependent manner, wher
eas a PI3 kinase inhibitor, wortmannin, could not. In addition, the suppres
sion of MMP secretion by S17N Ras showed good correlation with the inhibiti
on of in vitro invasiveness of the cells. In contrast, expression of domina
nt negative C3G did not suppress MMP secretion, although it substantially b
locked the c-Jun N-terminal kinase activation. Taken together, the Ras-MEK1
pathway, but not the C3G-JNK pathway, seems to play a key role in the acti
vation of MMP secretion and, hence, the invasiveness of v-crk-transformed c
ells.